Clinically relevant effect of a new intranasal therapy (MP29-02) in allergic rhinitis assessed by responder analysis.
Meltzer E, Ratner P, Bachert C, Carr W, Berger W, Canonica GW, Hadley J, Lieberman P, Hampel FC, Mullol J, Munzel U, Price D, Scadding G, Virchow JC, Wahn U, Murray R, Bousquet J.
Meltzer E, et al. Among authors: ratner p.
Int Arch Allergy Immunol. 2013;161(4):369-77. doi: 10.1159/000351404. Epub 2013 May 4.
Int Arch Allergy Immunol. 2013.
PMID: 23652808
Free article.
Clinical Trial.